Table 4. Soluble CD40 ligand levels (sCD40L) in patients without and with the primary and secondary endpoints in the subgroup of patients with angiographically-proven coronary artery disease (n = 459).

	No primary endpoint (n = 348)	Primary endpoint (n = 111)	p
sCD40L (ng/mL)	3.26 ± 0.16	3.38 ± 0.37	0.5
	No revascularization (n = 406)	Revascularization (n = 53)	p
sCD40L (ng/mL)	3.31 ± 0.16	3.14 ± 0.45	0.3
	No atherothrombotic event (n = 401)	Atherothrombotic event (n = 58)	p
sCD40L (ng/mL)	3.24 ± 0.15	3.59 ± 0.58	0.9

Continuous data are given as mean ± SEM.